Cargando…

Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives

INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Roszak, Sara E., Ferreri, Stefanie P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458117/
https://www.ncbi.nlm.nih.gov/pubmed/32816661
http://dx.doi.org/10.5888/pcd17.200050
_version_ 1783576130748416000
author Roszak, Sara E.
Ferreri, Stefanie P.
author_facet Roszak, Sara E.
Ferreri, Stefanie P.
author_sort Roszak, Sara E.
collection PubMed
description INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2 diabetes prevention programs by community pharmacies. METHODS: We conducted 21 semistructured interviews in 2018 with decision makers from 11 independent pharmacies in 6 US states and the District of Columbia and from 10 chain pharmacies operating in 1 state, multiple states, and nationwide. We identified participants by using purposive sampling. We used qualitative methods to analyze data and conducted interviews until we reached saturation. RESULTS: Multiple themes emerged: 1) initiation of services is more likely if initial financial support is received; 2) patient demand for services, actual or perceived, is paramount; 3) diabetes prevention services often fit within the existing operations of a pharmacy and allow maximum use of resources; 4) customer loyalty is a clearly articulated advantage against competition; and 5) engagement in diabetes prevention affirms an expanded role and the value of pharmacies to serve communities. CONCLUSION: Pharmacies are well situated to deliver diabetes prevention programs to communities. Although considerable opportunity exists for pharmacies to address diabetes prevention, more could be done to reduce barriers to their use.
format Online
Article
Text
id pubmed-7458117
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-74581172020-09-04 Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives Roszak, Sara E. Ferreri, Stefanie P. Prev Chronic Dis Original Research INTRODUCTION: Even though evidence-based diabetes prevention interventions exist, more than 1 in 3 Americans have prediabetes; the use of pharmacies has been explored as a way to reach and care for this population. The objective of this study was to analyze factors that influence adoption of type 2 diabetes prevention programs by community pharmacies. METHODS: We conducted 21 semistructured interviews in 2018 with decision makers from 11 independent pharmacies in 6 US states and the District of Columbia and from 10 chain pharmacies operating in 1 state, multiple states, and nationwide. We identified participants by using purposive sampling. We used qualitative methods to analyze data and conducted interviews until we reached saturation. RESULTS: Multiple themes emerged: 1) initiation of services is more likely if initial financial support is received; 2) patient demand for services, actual or perceived, is paramount; 3) diabetes prevention services often fit within the existing operations of a pharmacy and allow maximum use of resources; 4) customer loyalty is a clearly articulated advantage against competition; and 5) engagement in diabetes prevention affirms an expanded role and the value of pharmacies to serve communities. CONCLUSION: Pharmacies are well situated to deliver diabetes prevention programs to communities. Although considerable opportunity exists for pharmacies to address diabetes prevention, more could be done to reduce barriers to their use. Centers for Disease Control and Prevention 2020-08-20 /pmc/articles/PMC7458117/ /pubmed/32816661 http://dx.doi.org/10.5888/pcd17.200050 Text en https://creativecommons.org/licenses/by/4.0/Preventing Chronic Disease is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
Roszak, Sara E.
Ferreri, Stefanie P.
Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title_full Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title_fullStr Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title_full_unstemmed Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title_short Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives
title_sort community pharmacy engagement in diabetes prevention: key informant interviews with pharmacy executives
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458117/
https://www.ncbi.nlm.nih.gov/pubmed/32816661
http://dx.doi.org/10.5888/pcd17.200050
work_keys_str_mv AT roszaksarae communitypharmacyengagementindiabetespreventionkeyinformantinterviewswithpharmacyexecutives
AT ferreristefaniep communitypharmacyengagementindiabetespreventionkeyinformantinterviewswithpharmacyexecutives